Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

Sacco, R.; Diener, H.; Yusuf, S.; Cotton, Daniel; Ôunpuu, S.; A. Lawton, W.; Palesch, Y.; H. Martin, Renee'; Albers, G.; Bath, P.; Bornstein, N.; Chan, B.; Chen, Sien‐Tsong; Cunha, L.; Dahlöf, B.; De Keyser, J.; Donnan, G.; Estol, C.; Gorelick, P.; Gu, Vivian; Hermansson, K.; Hilbrich, Lutz; Kaste, M.; Lu, Chuanzhen; Machnig, T.; Pais, P.; Roberts, R.; Skvortsova, V.; Teal, P.; Toni, D.; P. VanderMaelen, Cam; Voigt, T.; Weber, M.; Yoon, B.

doi:10.1056/NEJMoa0805002

Public

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

Shared by NobleBlocks on Aug 27, 2008 • 12:00 AM UTC

Authors:

R. Sacco

H. Diener

S. Yusuf

Abstract

BACKGROUND Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of two antiplatelet regimens — aspirin plus extendedrelease dipyridamole (ASA–ERDP) versus clopidogrel. METHODS In this double-blind, 2-by-2 factorial trial, we randomly assi...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!